US 12,122,825 · Application 17/438,684 · Granted Oct 22, 2024
US 12,122,825
Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumor necrosis factor (tnf) antibody
Estimated expiration
February 10, 2041
14y 135d remaining
- Could not fetch continuity data for application PCTIB2020051635: Resource not found (404)
Earliest effective filing
Feb 26, 2020
+ 20 years
Feb 26, 2040
PTA +350d
Feb 10, 2041
TD applied
Feb 10, 2041
Final
Feb 10, 2041
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- September 13, 2021
- Earliest effective filing
- February 26, 2020
- Issue date
- October 22, 2024
- PTA
- +350 days
- Base expiry (before PTA)
- February 26, 2040
February 26, 2020 + 20 years = February 26, 2040 + 350 PTA days = February 10, 2041
- National stage entry of application PCTIB2020051635, filed Feb 26, 2020
- PRO62/818,316 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to February 10, 2041
US 12,122,825· Application 17/438,684(from application 17/438,684)Capping patent
Nucleic acid molecule encoding, and method of producing, a recombinant anti-tumor necrosis factor (tnf) antibody
- Filing date
- Sep 13, 2021
- Earliest effective filing
- Feb 26, 2020
- Issue date
- Oct 22, 2024
- PTA
- +350 days
- Calculated expiration
- Feb 10, 2041
National stage entry of PCTIB2020051635, filed Feb 26, 2020
Feb 26, 2020 + 20y + 350d PTA = Feb 10, 2041
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 17/438,684 · US 12,122,825
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,122,825: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12122825Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.